![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Eisai Gets Orphan Drug Status for Lenvatinib
Eisai Gets Orphan Drug Status for Lenvatinib
February 15, 2013
Eisai has received orpan-drug designation from the FDA for Lenvatinib, its investigational drug for thyroid cancer.
MarketWatch
MarketWatch
Upcoming Events
-
21Oct